Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Telmisartan I.P. 40mg + Cilnidipine I.P. 10mg Tablets
Therapeutic Category
Hypertension/ Blood Pressure, Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*15
Price
₹215/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Telbolife LN 40 Tablet is a combination medication containing Telmisartan 40mg and Cilnidipine 10mg. Telmisartan is an angiotensin II receptor blocker (ARB) that helps relax blood vessels and lower blood pressure, while Cilnidipine is a calcium channel blocker that dilates blood vessels and improves blood flow. Together, they provide effective management of hypertension by reducing vascular resistance and controlling blood pressure.
Possible side effects include dizziness, headache, flushing, edema, fatigue, and occasionally gastrointestinal disturbances.
Indicated for the treatment of essential hypertension to lower high blood pressure and reduce the risk of cardiovascular events.
Patients should take the medication as prescribed and avoid abrupt discontinuation. Regular monitoring of blood pressure and kidney function is advised. Consult a doctor before use if pregnant or breastfeeding.
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Metformin 1000mg (S.R.) Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Telmisartan + Cilnidipine Tablet is a strong-performing product in the cardiology, hypertension, and chronic care segment, making it a valuable addition to a PCD pharma franchise portfolio. With the rising prevalence of Hypertension across India, this combination enjoys consistent prescription demand from cardiologists, physicians, and general practitioners, ensuring stable long-term business potential for distributors and franchise partners.
Medical distributors and franchise partners can benefit from the strong demand for antihypertensive therapies. Commonly prescribed for the management of high blood pressure (Hypertension) under medical supervision Combines two complementary antihypertensive mechanisms for better BP control Frequently recommended by cardiologists and physicians Strong demand across hospitals, clinics, and retail pharmacy channels Long-term therapy ensures consistent repeat prescriptions Supports expansion into the growing cardiovascular care segment This strengthens a comprehensive cardiology and chronic care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Telmisartan 40 mg + Cilnidipine 10 mg Tablet with exclusive monopoly rights, promotional support, attractive packaging, and competitive pricing for distributors, stockists, and wholesalers across India.
Wholesalers and medical agencies can benefit from: Strong and consistent prescription demand in hypertension segment High repeat-order potential due to chronic therapy usage Strong acceptance among cardiologists and physicians Reliable product availability and supply chain support Attractive business margins and long-term growth opportunities Expanding cardiovascular disease management market across India These advantages contribute to sustainable sales growth and business expansion.
Interested distributors, stockists, and pharma entrepreneurs can partner with Cafoli LifeCare Pvt Ltd to access profitable PCD pharma franchise opportunities for Telmisartan 40 mg + Cilnidipine 10 mg Tablet. With exclusive monopoly rights, comprehensive promotional support, quality-assured formulations, attractive profit margins, and dependable logistics services, Cafoli LifeCare Pvt Ltd helps franchise partners establish and expand a successful pharmaceutical business across India.